EarlyTox Cell Integrity Assay Kit

A new cell viability assay from Molecular Devices.

By | April 3, 2014

Request More Information

The EarlyTox™ Cell Integrity Kit from Molecular Devices is a fluorescence-based cell viability assay integrated with the company’s existing hardware and software for quick IC50 analysis in adherent and non-adherent cells. The kit is equipped with brighter fluorophores that shorten exposure times and increase throughput. An optional masking reagent reduces background, eliminating the need for time-consuming media removal and washes.

The kit employs a two-color system to distinguish live and dead cells. A red “live” dye enters all cells, staining the nuclei red. A green “dead” dye permeates only those cells with compromised membranes, staining the nuclei green

Using the SpectraMax® MiniMax™ 300 Imaging Cytometer and pre-configured protocols for the SoftMax® Pro Software, a 96-well plate can be assessed in five minutes and an IC50 curve automatically generated

Request More Information

Product Details

Molecular Devices EarlyTox Cell Integrity Kit

image of: Molecular Devices EarlyTox Cell Integrity Kit

Request More Information

Your Request
About You
Enter text from the image above:

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech